Overall, our findings in triple-vaccinated HCW with different previous SARS-CoV-2 infectionhistories indicated that T cell cross-recognition of B.1.1.529(Omicron) S1 antigen and peptide pool was significantly reduced. The gene discussed is PSMD1; the disease is COVID-19.